In today's world, Methdilazine has become a topic of great relevance and interest to a wide spectrum of people. Both professionally and personally, Methdilazine has generated debates and discussions about its impact and influence on society. From its origin to its current evolution, Methdilazine has been the subject of studies and research that have tried to shed light on its implications and consequences. In this article, we will explore some fundamental aspects of Methdilazine and analyze its role in different contexts. From its connection with technology, through its relationship with culture and politics, to its importance in everyday life, Methdilazine is a topic that continues to generate interest and reflection today.
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.220 |
Chemical and physical data | |
Formula | C18H20N2S |
Molar mass | 296.43 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Methdilazine (Dilosyn, Tacaryl) is a first-generation antihistamine with anticholinergic properties of the phenothiazine class.
The ring-contracted analog, methdilazine shows only very weak activity as a tranquilizer; instead, that agent constitutes an important antihistamine.